1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile
about
The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognitionThe structure of the catalytic domain of Tannerella forsythia karilysin reveals it is a bacterial xenologue of animal matrix metalloproteinasesStructural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of -Amyloid Precursor Protein-derived InhibitorStructural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexesMatrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?Targeting the tumor microenvironment by immunotherapy: part 2.Targeting angiogenesis for treatment of human cancerPharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency. An explanation of inhibitor selectivity using homology modeling and chimeric proteins.
P2860
Q27630877-F2071E41-7556-47C1-9D5B-1381D94745CCQ27666329-D947163C-5114-476D-88ED-DFE00B4BAFD2Q27671479-748A51EC-986B-42CB-BBF0-61FFD363166AQ28144131-40F01B63-CC23-49B4-B7A6-AA6694D2E628Q37412311-0B697AB0-F7CA-4965-BF54-D20D6E382FAEQ37551933-08348DBD-618E-432D-AB0F-C1F227B4B2EBQ37952796-7A077342-2243-4C4D-A3F0-96AC497CA85DQ38125442-78886117-0452-4FA8-8812-6720E6468CE3Q38725320-78CCAAFF-D156-4745-AA55-FA010190678BQ38836225-E9474D13-B5FC-4316-A737-68B2A810101EQ39197180-41ED531C-18DC-46BD-BA08-2283FB415B59Q39506214-324FDAA1-5A1C-48AF-A646-38B70AF0CFE9Q40670634-32CAF6B5-6215-4F4A-B9D6-9C01B22BD820Q46943098-76B288A3-CC5B-41A1-8A5D-AA924E7120DAQ47936331-CBB18C4A-EB07-4580-8EAF-99C0EC32D0FB
P2860
1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
1.8-A crystal structure of the ...... a distinct selectivity profile
@ast
1.8-A crystal structure of the ...... a distinct selectivity profile
@en
1.8-A crystal structure of the ...... a distinct selectivity profile
@nl
type
label
1.8-A crystal structure of the ...... a distinct selectivity profile
@ast
1.8-A crystal structure of the ...... a distinct selectivity profile
@en
1.8-A crystal structure of the ...... a distinct selectivity profile
@nl
prefLabel
1.8-A crystal structure of the ...... a distinct selectivity profile
@ast
1.8-A crystal structure of the ...... a distinct selectivity profile
@en
1.8-A crystal structure of the ...... a distinct selectivity profile
@nl
P2093
P2860
P1433
P1476
1.8-A crystal structure of the ...... a distinct selectivity profile
@en
P2093
F X Gomis-Rüth
H Tschesche
S J Davies
P2860
P304
P356
10.1111/J.1432-1033.1997.00356.X
P407
P577
1997-07-01T00:00:00Z